MILRINONE LACTATE IN DEXTROSE 5% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Milrinone Lactate In Dextrose 5%, and when can generic versions of Milrinone Lactate In Dextrose 5% launch?
Milrinone Lactate In Dextrose 5% is a drug marketed by Eugia Pharma, Woodward, B Braun, Baxter Hlthcare, Gland Pharma Ltd, Hikma, Hospira, and West-ward Pharms Int. and is included in nine NDAs.
The generic ingredient in MILRINONE LACTATE IN DEXTROSE 5% is milrinone lactate. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the milrinone lactate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Milrinone Lactate In Dextrose 5%
A generic version of MILRINONE LACTATE IN DEXTROSE 5% was approved as milrinone lactate by FRESENIUS KABI USA on May 28th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MILRINONE LACTATE IN DEXTROSE 5%?
- What are the global sales for MILRINONE LACTATE IN DEXTROSE 5%?
- What is Average Wholesale Price for MILRINONE LACTATE IN DEXTROSE 5%?
Summary for MILRINONE LACTATE IN DEXTROSE 5%
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 5 |
| Clinical Trials: | 5 |
| DailyMed Link: | MILRINONE LACTATE IN DEXTROSE 5% at DailyMed |
Recent Clinical Trials for MILRINONE LACTATE IN DEXTROSE 5%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Shanghai Children's Medical Center | Phase 3 |
| Ottawa Heart Institute Research Corporation | Phase 4 |
| Thrasher Research Fund | N/A |
Pharmacology for MILRINONE LACTATE IN DEXTROSE 5%
| Drug Class | Phosphodiesterase 3 Inhibitor |
| Mechanism of Action | Phosphodiesterase 3 Inhibitors |
US Patents and Regulatory Information for MILRINONE LACTATE IN DEXTROSE 5%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | MILRINONE LACTATE IN DEXTROSE 5% | milrinone lactate | INJECTABLE;INJECTION | 209666-001 | Sep 3, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Baxter Hlthcare | MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 075834-002 | May 28, 2002 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| B Braun | MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 076414-001 | Aug 18, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 075885-002 | May 28, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Gland Pharma Ltd | MILRINONE LACTATE IN DEXTROSE 5% IN PLASTIC CONTAINER | milrinone lactate | INJECTABLE;INJECTION | 213585-001 | Jul 16, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
